The Menopause Society

The Menopause Society logo and text reading "vaginal estrogen therapy use in survivors of endometrial cancer".

A new study suggests local, low-dose #vaginalestrogen therapy is not only effective in relieving numerous menopause symptom for survivors of #endometrialcancer, but also does not seem to increase a woman’s risk of cancer recurrence.

Read more at tinyurl.com/25w3b7ut.

#hormonetherapy #menopause

Doctor Holly Thomas and Doctor Rebecca Manno, the Menopause Step-by-Step webinar series logo and text reading "Joint Pain and Menopause".

Members, join us on Wed, March 18, for the next Menopause Step-by-Step webinar. Dr Holly Thomas and Dr Rebecca Manno will discuss “Joint Pain and #Menopause.” Register in the Member Center on our site. If you can’t join us live, it will be recorded/posted in the Member Center.

#menopausestepbystep

REMINDER: THIS IS SCHEDULED FOR THIS WEEK.

"Graphic with The Menopause Society Leading the Conversation logo and text reading Nonablative Radiofrequency May Improve Sexual Function in Postmenopausal Women".

A new study provides preliminary evidence that suggests effectiveness of nonablative radiofrequency on sexual function and vaginal health.

Read more at tinyurl.com/2xcmxdtz.

#menopause #gsm #genitourinarysyndromeofmenopause

"Graphic with The Menopause Society Leading the Conversation logo and text reading Initiation of Hormone Therapy After Age 65".

A new study evaluated the health outcomes of hormone therapy (HT) in women aged 65 years and older, including women who initiated HT after age 65 years. Read more at tinyurl.com/yuu4t8t9.

#menopause #hormonetherapy

"Menopause Step-by-Step webinar series logo, photos of doctors Jan Shifren and Caroline Mitchell, and text reading evaluation and diagnosis of common vulvar disorders in midlife and beyond".

Members, join us Wed, Feb 25, for the next #Menopause Step-by-Step webinar. Drs Jan Shifren and Caroline Mitchell will discuss “Evaluation and Diagnosis of Common #VulvarDisorders in Midlife and Beyond.” Register in the Member Center on our site. It will be also recorded/posted in the Member Center.

The Menopause Society Leading the Conversation logo and text reading "global perspectives on perimenopause".

Although #perimenopause is experienced by all women regardless of race or nationality, it is not always experienced similarly. A new study indicates inconsistency between perimenopause knowledge and actual symptoms experienced across diverse global populations.

More at tinyurl.com/ytujcrhh.

"The Menopause Society Leading the Conversation logo and text reading hormone therapy underused in patients with premature ovarian insufficiency".

A new study suggests that misinformation is keeping women with premature ovarian insufficiency from getting the help they need, despite proven benefits of hormone therapy.

Read more at: tinyurl.com/38dzyupj.

#prematureovarianinsufficiency #hormonetherapy

Reminder: This is scheduled for this week!

Doctor Matthew Nudy.

Congratulations to Dr Matthew S Nudy, who is newly appointed to The Menopause Society's Board of Trustees!

"The Menopause Society logo and text reading Welcome Tracy Huckabee Chief Learning Officer".

Please join us in welcoming Tracy in her new role as chief learning officer. We look forward to working with her as we continue to enhance and shape the future of menopause education and develop a robust digital learning platform to deliver concise, evidence-based education.

Graphic with The Menopause Society logo and text reading "Diabetes risk is not associated with timing or type of menopause".

Timing and type of menopause are not risk factors for the onset of diabetes.

Read more at tinyurl.com/sj9j83yd.

#menopause #diabetes

"Call for Abstracts, The Menopause Society, 2026 Annual Meeting, October 20-24, 2026, Hilton Bayfront, San Diego".

Submit your research for presentation at this year’s Annual Meeting.

The submission deadline for abstracts is March 31, 2026.

Submit online at menopause.org/annual-meeti....

#menopause #menopauseresearch

"Menopause Step-by-Step webinar series logo, photos of doctors Cheryl Kinney and Donna Plecha, and text reading 'breast cancer screening in midlife and beyond'".

Members, please join us on Wednesday, January 21, for the next #Menopause Step-by-Step webinar. Dr Cheryl Kinney and Dr Donna Plecha will discuss “Breast Cancer Screening in Midlife and Beyond.” Register in the Member Center on our site. It will also be recorded and posted in the Member Center.

Reminder: This is scheduled for this week

"Doctors Claudio Soares and Cheryl Kinney, the Menopause step-by-step webinar series logo and text reading 'Night Sweats: What If It's Not Menopause?".

Members, please join us Dec 17, for the next Menopause Step-by-Step webinar. Drs Claudio Soares and Cheryl Kinney will discuss “#NightSweats: What If It’s Not #Menopause?” Register in the Member Center on our website. If you can’t join the live webinar, it will be posted in the Member Center.

Doctors Daniela Hurtado and Sara Looby with the a graphic reading "Leading the Conversation, The Menopause Society Show".

New #menopauseeducation! Leading the Conversation: The Menopause Society Show, addresses common yet challenging clinical issues that healthcare professionals face in their care of women during the #menopause transition and beyond and provides guidelines for management. tinyurl.com/39pafebv.
#weight

"A photo of multiple different sex toys".

A recent study looked at sex-toy use during partnered sex and masturbation in older adult women.

Read more at tinyurl.com/mtxuyh8u.

#sexualhealth #masturbation #orgasm #midlife

The Menopause Society logo and Leading the Conversation tagline with text reading "Are there different indications for the use of systemic and vaginal estrogen?".

"Q: Are there different indications for use of systemic & vaginal estrogen? Yes. Low-dose vaginal estrogen is used for managing genitourinary symptoms, such as vulvovaginal dryness, itching, irritation, & pain with sexual activity, along with urinary symptoms of urgency and frequency. There are also data suggesting that it reduces the risk of urinary tract infections in postmenopausal women. Systemic estrogen is US-gov't approved for management of vasomotor symptoms & prevention of bone loss & may have some beneficial effects for sleep & mood. Systemic estrogen may also be effective for managing genitourinary symptoms, but the use of low-dose vaginal estrogen is preferred in women who are only experiencing these symptoms. For women on systemic HT who continue to experience genitourinary symptoms, the addition of local, low-dose estrogen may be needed. References: The 2022 HT Position Statement of The Menopause Society Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline".

Question: Are there different indications for the use of systemic and vaginal estrogen?

Yes. See the second graphic for details. #hormonetherapy #menopause

References:
tinyurl.com/22v85s8f
tinyurl.com/y5k6b3py

The Menopause Society logo and Leading the Conversation tagline with text reading "Are there benefits to starting hormone therapy before menopause onset?".

"Question: Are there benefits to starting hormone therapy before menopause onset? No. There is no data to support the use in perimenopause to “prevent” menopause or chronic disease. Although hormone therapy can be used for symptom management in perimenopause, it is not a high-enough dose to prevent pregnancy or to control heavy menstrual bleeding. It can be used in combination with a progestin-containing intrauterine device that does provide contraception. Alternatively, a low-dose hormone contraceptive pill/patch/ring may also be an option for contraception, management of heavy menstrual bleeding, and symptom management in perimenopausal women. Reference: Practice Pearl: Contraception in Perimenopause".

Q: Are there benefits to starting #hormonetherapy before #menopause onset?
A: No. There is no data to support the use of HT in #perimenopause. Although #hormonetherapy can be used for symptom management in perimenopause, it is not a high-enough dose to prevent pregnancy or to control heavy bleeding.

The Menopause society logo and leading the conversation tagline with text reading "should hormone therapy be used for weight loss?".

"Question: Should hormone therapy be used for weight loss? No. Hormone therapy has favorable effects on body composition but typically does not result in weight loss. There is a link between adiposity and menopause symptoms. Adiposity, and particularly central adiposity, is associated with increased vasomotor symptom severity. Although weight loss via lifestyle intervention has been associated with decreased frequency and severity of vasomotor symptoms, the effect of weight loss medications on vasomotor symptoms is limited. There is preliminary evidence that hormone therapy use may augment response to weight loss medications, but additional study is needed before this can be recommended as standard practice in clinical care. References: The 2022 Hormone Therapy Position Statement of The Menopause Society Practice Pearl: Pharmacologic Options for the Treatment of Overweight and Obesity".

Question: Should hormone therapy be used for weight loss?

No. Hormone therapy has favorable effects on body composition but typically does not result in weight loss. See more in second image.

#hormonetherapy #weight #menopause

Graphic is The Menopause Society logo and Leading the Conversation tagline and text reading " I am in my 60s. Is it too late to start hormone therapy?".

Question: I am in my 60s. Is it too late to start hormone therapy? It depends. There is nothing magic about the age of 60 with regard to starting hormone therapy. More important are time since menopause, with risks being lower in women who are within 10 years of menopause onset, existing contraindications, risk factors for cardiovascular disease and breast cancer, and reasons for initiating hormone therapy (eg, bone protection, hot flash management). Hormone therapy should not be used for prevention of heart disease, dementia, or aging in general. Shared decision-making between women and their clinicians is essential, because these discussions are often nuanced. References: The 2022 Hormone Therapy Position Statement of The Menopause Society The Menopause Society Statement on Hormone Therapy Misinformation

Question: I am in my 60s. Is it too late to start #hormonetherapy?

It depends. Shared decision-making between women and their clinicians is essential, because these discussions are often nuanced. See second image for more information.

References:
tinyurl.com/22v85s8f
tinyurl.com/ydwttjkv

Graphic is The Menopause Society logo and Leading the Conversation tagline and text reading "does hormone therapy prevent bone loss and protect against fracture risk?".

"Question: Does hormone therapy prevent bone loss and protect against fracture risk? Yes. Hormone therapy is US-government approved for prevention of bone loss and can be used for this purpose in women who do not have contraindications and who are appropriate candidates. Hormone therapy prevents bone loss and reduces fracture risk in healthy, postmenopausal women, with dose-related effects on bone density. Hormone therapy is not US-government approved for treatment of osteoporosis, and other management strategies should be considered in women with osteoporosis. Stopping hormone therapy results in initial rapid bone loss and potentially in transiently increased fracture risk with longer-term protection. Unless contraindicated, women with premature menopause should use hormone therapy to prevent bone loss and reduce fracture risk until the average age of menopause when treatment may be reassessed. References: The 2022 Hormone Therapy Position Statement of The Menopause Society Discontinuation of Menopausal Hormone Therapy and Risk of Fracture".

Does #hormonetherapy prevent bone loss and protect against fracture risk?

Yes. HT is US-government approved for prevention of #boneloss and can be used for this purpose in appropriate candidates who do not have contraindications.
References: tinyurl.com/22v85s8f tinyurl.com/35kf8h8v

#hormonetherapy #menopause #dementia #cognition

"Graphic with The Menopause Society logo and tagline Leading the Conversation along with text reading 'Should hormone therapy be used to prevent dementia?'".

"Question: Should hormone therapy be used to prevent dementia? No. Hormone therapy is not recommended for prevention or treatment of cognitive decline or dementia. At the present time, we do not have evidence that the use of hormone therapy in women undergoing menopause at the usual age prevents dementia. It may have cognitive benefits when started in women after hysterectomy and oophorectomy before menopause onset. The risk of dementia was increased in women aged older than 65 years who initiated conjugated equine estrogens plus medroxyprogesterone acetate in the Women’s Health Initiative Memory Study. Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society".

Question: Should hormone therapy be used to prevent dementia?

No. #Hormonetherapy is not recommended for prevention or treatment of cognitive decline or #dementia.

Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f. #menopause

"Question: Should hormone therapy be used to prevent heart disease? No. Hormone therapy is not recommended for primary or secondary prevention of cardiovascular disease. The effects of hormone therapy on coronary heart disease (CHD) vary depending on when it is initiated in relation to time since menopause and age. In younger women who are within 10 years of menopause onset, there is a favorable effect on CHD and all-cause mortality that needs to be considered against potential rare increases in risks of breast cancer, venous thromboembolism, and stroke. Women who initiate hormone therapy 20 to 30 years after the onset of menopause are at higher risk of coronary heart disease, venous thromboembolism, and stroke than women initiating hormone therapy early in menopause. Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society".

"Graphic with The Menopause Society logo and tagline Leading the Conversation along with text reading 'Should hormone therapy be used to prevent heart disease?'".

Should hormone therapy be used to prevent #heartdisease?

No. #Hormonetherapy is not recommended for primary or secondary prevention of #cardiovasculardisease.

Reference: The 2022 Hormone Therapy Position Statement of The Menopause Society available at tinyurl.com/22v85s8f

#menopause

REMINDER: This is scheduled for this week!

US health leaders hailed the benefits of hormone therapy for menopause. Doctors are pushing for balance | CNN Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal symp...

www.cnn.com/2025/11/12/h...

#menopause #hormonetherapy

"A woman lies in bed looking at an alarm clock displaying the time of 3:35".

A new study suggests sleep-related disorders in postmenopausal women may increase their risk of hypertension. #menopause #sleepdisorders #postmenopause #hypertension

tinyurl.com/td8kwxs3